Bryan Richard Hinton - 02 Dec 2021 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Role: Chief Technology Officer
Signature: /s/ Daniel Orenstein, as Attorney-in-Fact
Issuer symbol: HCAT
Transactions as of: 02 Dec 2021
Net transactions value: -$375,073
Form type: 4
Filing time: 07 Dec 2021, 15:14:06 UTC
Previous filing: 30 Nov 2021
Next filing: 29 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCAT	Common Stock	Tax liability	$122,403	-2,918	-16%	$41.95	15,832	02 Dec 2021	Direct	F1, F2
transaction	HCAT	Common Stock	Options Exercise	$1,132	+105	+0.66%	$10.78	15,937	03 Dec 2021	Direct
transaction	HCAT	Common Stock	Sale	$4,501	-105	-0.66%	$42.87	15,832	03 Dec 2021	Direct	F3
transaction	HCAT	Common Stock	Sale	$52,772	-1,400	-8.8%	$37.69	14,432	06 Dec 2021	Direct	F3, F4
transaction	HCAT	Common Stock	Sale	$195,396	-5,057	-35%	$38.64	9,375	06 Dec 2021	Direct	F3, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HCAT	Stock Option (Right to Buy)	Options Exercise	$1,132	-105	-17%	$10.78	529	03 Dec 2021	Common Stock	105	$10.78	Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
F2	Represents a weighted average price reported by the broker. These shares were sold as part of a block trade in multiple transactions at prices ranging from $40.33 to $42.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote with regard to the block trade.
F3	The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 3, 2021, in accordance with Rule 10b5-1.
F4	Represents the weighted average sale price of the shares sold ranging from $37.35 to $38.21 per share, inclusive.
F5	Represents the weighted average sale price of the shares sold ranging from $38.37 to $39.06 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (4) and (5).
F6	25% of the 5,082 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on May 3, 2022.